Suberohydroxamic acid phenyl ester: Interim Phase II data

Interim data from 34 stage Ia-IIa CTCL patients in an open-label, U.S. Phase II trial showed that once-daily

Read the full 185 word article

How to gain access

Continue reading with a
two-week free trial.